These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 10400418)
1. Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemia cells. Blagosklonny MV; Chuman Y; Bergan RC; Fojo T Leukemia; 1999 Jul; 13(7):1028-36. PubMed ID: 10400418 [TBL] [Abstract][Full Text] [Related]
2. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells. Huang Y; Sheikh MS; Fornace AJ; Holbrook NJ Oncogene; 1999 Jun; 18(23):3431-9. PubMed ID: 10376521 [TBL] [Abstract][Full Text] [Related]
3. Involvement of Asp-Glu-Val-Asp-directed, caspase-mediated mitogen-activated protein kinase kinase 1 Cleavage, c-Jun N-terminal kinase activation, and subsequent Bcl-2 phosphorylation for paclitaxel-induced apoptosis in HL-60 cells. Shiah SG; Chuang SE; Kuo ML Mol Pharmacol; 2001 Feb; 59(2):254-62. PubMed ID: 11160861 [TBL] [Abstract][Full Text] [Related]
4. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Blagosklonny MV; Giannakakou P; el-Deiry WS; Kingston DG; Higgs PI; Neckers L; Fojo T Cancer Res; 1997 Jan; 57(1):130-5. PubMed ID: 8988053 [TBL] [Abstract][Full Text] [Related]
5. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2. Wen-Sheng W Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661 [TBL] [Abstract][Full Text] [Related]
6. Selective potentiation of paclitaxel (taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines. McDaid HM; Horwitz SB Mol Pharmacol; 2001 Aug; 60(2):290-301. PubMed ID: 11455016 [TBL] [Abstract][Full Text] [Related]
7. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Blagosklonny MV; Schulte T; Nguyen P; Trepel J; Neckers LM Cancer Res; 1996 Apr; 56(8):1851-4. PubMed ID: 8620503 [TBL] [Abstract][Full Text] [Related]
8. Sequence-dependent potentiation of paclitaxel-mediated apoptosis in human leukemia cells by inhibitors of the mitogen-activated protein kinase kinase/mitogen-activated protein kinase pathway. Yu C; Wang S; Dent P; Grant S Mol Pharmacol; 2001 Jul; 60(1):143-54. PubMed ID: 11408609 [TBL] [Abstract][Full Text] [Related]
9. A dominant role for the Raf-MEK pathway in forskolin, 12-O-tetradecanoyl-phorbol acetate, and platelet-derived growth factor-induced CREB (cAMP-responsive element-binding protein) activation, uncoupled from serine 133 phosphorylation in NIH 3T3 cells. Seternes OM; Johansen B; Moens U Mol Endocrinol; 1999 Jul; 13(7):1071-83. PubMed ID: 10406459 [TBL] [Abstract][Full Text] [Related]
10. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells. Wang TH; Popp DM; Wang HS; Saitoh M; Mural JG; Henley DC; Ichijo H; Wimalasena J J Biol Chem; 1999 Mar; 274(12):8208-16. PubMed ID: 10075725 [TBL] [Abstract][Full Text] [Related]
11. Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits. Moos PJ; Fitzpatrick FA Cell Growth Differ; 1998 Aug; 9(8):687-97. PubMed ID: 9716185 [TBL] [Abstract][Full Text] [Related]
12. The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways. Boldt S; Weidle UH; Kolch W Exp Cell Res; 2003 Feb; 283(1):80-90. PubMed ID: 12565821 [TBL] [Abstract][Full Text] [Related]
13. Activation of Raf-1 and mitogen-activated protein kinases during monocytic differentiation of human myeloid leukemia cells. Kharbanda S; Saleem A; Emoto Y; Stone R; Rapp U; Kufe D J Biol Chem; 1994 Jan; 269(2):872-8. PubMed ID: 8288641 [TBL] [Abstract][Full Text] [Related]
14. 2-Methoxyestradiol-induced phosphorylation of Bcl-2: uncoupling from JNK/SAPK activation. Attalla H; Westberg JA; Andersson LC; Adlercreutz H; Mäkelä TP Biochem Biophys Res Commun; 1998 Jun; 247(3):616-9. PubMed ID: 9647742 [TBL] [Abstract][Full Text] [Related]
15. Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C. Townsend KJ; Trusty JL; Traupman MA; Eastman A; Craig RW Oncogene; 1998 Sep; 17(10):1223-34. PubMed ID: 9771965 [TBL] [Abstract][Full Text] [Related]
16. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells. Okumura K; Shirasawa S; Nishioka M; Sasazuki T Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756 [TBL] [Abstract][Full Text] [Related]
17. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Marquardt B; Frith D; Stabel S Oncogene; 1994 Nov; 9(11):3213-8. PubMed ID: 7936644 [TBL] [Abstract][Full Text] [Related]
18. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells. Stone AA; Chambers TC Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471 [TBL] [Abstract][Full Text] [Related]
19. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia. Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369 [TBL] [Abstract][Full Text] [Related]
20. Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1. Fan M; Du L; Stone AA; Gilbert KM; Chambers TC Cancer Res; 2000 Nov; 60(22):6403-7. PubMed ID: 11103805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]